{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T23:26:25Z","timestamp":1770506785643,"version":"3.49.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.jad.2010.04.005","type":"journal-article","created":{"date-parts":[[2010,6,8]],"date-time":"2010-06-08T04:38:08Z","timestamp":1275971888000},"page":"358-365","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":79,"title":["Asenapine for long-term treatment of bipolar disorder: A double-blind 40-week extension study"],"prefix":"10.1016","volume":"126","author":[{"given":"Roger S.","family":"McIntyre","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larry","family":"Alphs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas A.","family":"Macek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Panagides","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2010.04.005_bib1","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1136\/emj.2003.008870","article-title":"Value of serum prolactin in the management of syncope","volume":"21","author":"Ahmad","year":"2004","journal-title":"Emerg. Med. J."},{"key":"10.1016\/j.jad.2010.04.005_bib2","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1192\/bjp.154.5.672","article-title":"A rating scale for drug-induced akathisia","volume":"154","author":"Barnes","year":"1989","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2010.04.005_bib3","doi-asserted-by":"crossref","first-page":"s8","DOI":"10.1111\/j.1528-1167.2005.463003.x","article-title":"Epidemiology of bipolar disorders","volume":"46","author":"Bauer","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.jad.2010.04.005_bib4","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1007\/s11920-006-0058-3","article-title":"Acute treatment of mania: an update on new medications","volume":"8","author":"Gajwani","year":"2006","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.jad.2010.04.005_bib5","series-title":"Clinical Global Impressions","first-page":"217","article-title":"Clinical global impressions","author":"Guy","year":"1976"},{"key":"10.1016\/j.jad.2010.04.005_bib6","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.4088\/JCP.08m04895yel","article-title":"Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study","volume":"70","author":"Houston","year":"2009","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2010.04.005_bib7","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0165-0327(02)00332-4","article-title":"The prevalence and disability of bipolar spectrum disorders in the US population: re-analysis of the ECA database taking into account subthreshold cases","volume":"73","author":"Judd","year":"2003","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2010.04.005_bib8","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1001\/archpsyc.65.4.386","article-title":"Residual symptom recovery from major affective episodes in bipolar disorders and rapid episode relapse\/recurrence","volume":"65","author":"Judd","year":"2008","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2010.04.005_bib9","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jad.2007.06.014","article-title":"Psychosocial disability and work role function compared across the long-term course of bipolar I, bipolar II and unipolar major depressive disorders","volume":"108","author":"Judd","year":"2008","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2010.04.005_bib10","first-page":"120","article-title":"Mood stabilizers and atypical antipsychotics: bimodal treatments for bipolar disorder","volume":"39","author":"Ketter","year":"2006","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.jad.2010.04.005_bib11","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1399-5618.2009.00748.x","article-title":"A 3-week, randomized, placebo-controlled trial of asenapine in the treatment of acute mania in bipolar mania and mixed states","volume":"11","author":"McIntyre","year":"2009","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2010.04.005_bib12","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/j.1399-5618.2009.00749.x","article-title":"Asenapine versus olanzapine in acute mania: a double-blind extension study","volume":"11","author":"McIntyre","year":"2009","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2010.04.005_bib13","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jad.2009.12.028","article-title":"Asenapine in the treatment of acute mania in bipolar I disorder: a randomized, double-blind, placebo-controlled trial","volume":"122","author":"McIntyre","year":"2010","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2010.04.005_bib14","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1001\/archpsyc.64.5.543","article-title":"Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication","volume":"64","author":"Merikangas","year":"2007","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2010.04.005_bib15","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/0364-7722(79)90058-4","article-title":"Depressive symptoms in acute schizophrenia","volume":"3","author":"Montgomery","year":"1979","journal-title":"Prog. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2010.04.005_bib16","first-page":"1172","article-title":"How to examine patients using the Abnormal Involuntary Movement Scale","volume":"39","author":"Munetz","year":"1988","journal-title":"Hosp. Community Psychiatry"},{"key":"10.1016\/j.jad.2010.04.005_bib28","unstructured":"Saphris\u00ae (asenapine) sublingual tablets. Full Prescribing Information. Schering-Plough, Kenilworth, NJ; 2009"},{"key":"10.1016\/j.jad.2010.04.005_bib17","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1097\/chi.0b013e3180335ae4","article-title":"Response and remission in adolescent mania: signal detection analyses of the young mania rating scale","volume":"46","author":"Patel","year":"2007","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.jad.2010.04.005_bib18","doi-asserted-by":"crossref","DOI":"10.1055\/s-0030-1248313","article-title":"Long-term assessment of asenapine vs. olanzapine in patients with schizophrenia or schizoaffective disorder","author":"Schoemaker","year":"2010","journal-title":"Pharmacopsychiatry"},{"issue":"1","key":"10.1016\/j.jad.2010.04.005_bib19","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1177\/0269881107082944","article-title":"Asenapine: a novel psychopharmacologic agent with a unique human receptor signature","volume":"23","author":"Shahid","year":"2009","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jad.2010.04.005_bib20","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.neuint.2004.10.007","article-title":"Bipolar disorder: an update","volume":"46","author":"Shastry","year":"2005","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.jad.2010.04.005_bib21","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","article-title":"A rating scale for extrapyramidal side effects","volume":"212","author":"Simpson","year":"1970","journal-title":"Acta Psychiatr. Scand. Suppl."},{"key":"10.1016\/j.jad.2010.04.005_bib22","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1176\/appi.ajp.163.2.247","article-title":"Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine","volume":"163","author":"Tohen","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2010.04.005_bib23","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jad.2008.06.001","article-title":"Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126)","volume":"109","author":"Vieta","year":"2008","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2010.04.005_bib24","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1080\/15622970701530917","article-title":"A long-term prospective study on the outcome of bipolar patients treated with long-acting injectable risperidone","volume":"9","author":"Vieta","year":"2008","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2010.04.005_bib25","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/hup.556","article-title":"Acute and continuation risperidone monotherapy in mania","volume":"19","author":"Vieta","year":"2004","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.jad.2010.04.005_bib26","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1017\/S1092852900014917","article-title":"The use of antiepileptic drugs in bipolar disorders: a review based on evidence from controlled trials","volume":"11","author":"Weisler","year":"2006","journal-title":"CNS Spectr."},{"key":"10.1016\/j.jad.2010.04.005_bib27","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: reliability, validity and sensitivity","volume":"133","author":"Young","year":"1978","journal-title":"Br. J. Psychiatry"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032710003411?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032710003411?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T01:09:15Z","timestamp":1759021755000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032710003411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S0165032710003411"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2010.04.005","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Asenapine for long-term treatment of bipolar disorder: A double-blind 40-week extension study","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2010.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}